INS and Alzheimer disease: Previous investigations indicated that chronic inflammation and oxidative stress are the two key factors connecting T2DM to AD via impairing cerebral insulin signaling and disturbing amyloid-β (Aβ) protein metabolism (Verdile et al., 2015).